FIELD: medicine; pharmaceutics.
SUBSTANCE: invention refers to pharmacology and medicine and concerns ethonogestrel new esters of formula 1 , 2
, 3
, applied for male and female contraception. Compositions are characterised by improved disposition profile.
EFFECT: production of composition with improved disposition profile.
3 cl, 2 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
CONTRACEPTIVE INJECTION OF OIL SOLUTION INJECTED INDEPENDENTLY | 2003 |
|
RU2328289C2 |
USE OF NOVEL ETHONOGESTREL ESTERS | 2003 |
|
RU2322986C2 |
COMPOUNDS, SET, ANDROGENIC COMPOSITION | 2000 |
|
RU2242479C2 |
CRYSTALLINE FORMS OF CORTEXOLONE-17α-PROPIONATE AND METHOD FOR PREPARING THEM | 2008 |
|
RU2482190C2 |
ESTER COMPOUNDS AND THEIR USING IN MEDICINE | 2003 |
|
RU2293721C2 |
DERIVATIVES OF DIAMINES | 2002 |
|
RU2319699C2 |
DIAMINE DERIVATIVES | 2002 |
|
RU2314303C2 |
CRYSTALLINE SOLVATE FORM OF CORTEXOLONE-17alpha-PROPIONATE, A PREPARATION METHOD THEREOF AND A PHARMACEUTICAL COMPOSITION BASED THEREON | 2012 |
|
RU2599452C2 |
PHENYLIMIDAZOLE COMPOUNDS | 2010 |
|
RU2497811C2 |
DERIVATIVES OF ESTRA-1,3,5(10)-TRIENE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2139885C1 |
Authors
Dates
2008-06-10—Published
2003-05-22—Filed